|
rs1042522
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The results suggest that P72R polymorphisms may be associated with an increased PCM risk and may affect OS of PCM patients.
|
29333597 |
2017 |
|
rs1131691014
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The results suggest that P72R polymorphisms may be associated with an increased PCM risk and may affect OS of PCM patients.
|
29333597 |
2017 |
|
rs878854066
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The results suggest that P72R polymorphisms may be associated with an increased PCM risk and may affect OS of PCM patients.
|
29333597 |
2017 |
|
rs1042522
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Through searching PubMed databases (or hand searching) up to April 2012 using the following MeSH terms and keywords: "p53", "codon 72" "polymorphism" and "leukemia", or "lymphoma", or "myeloma", thirteen were identified as eligible articles in this meta-analysis for p53 Arg72Pro polymorphism (2,731 cases and 7, 356 controls), including nine studies on leukemia (1,266 cases and 4, 474 controls), three studies on lymphoma (1,359 cases and 2,652 controls), and one study on myeloma.
|
23029260 |
2012 |
|
rs1131691014
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Through searching PubMed databases (or hand searching) up to April 2012 using the following MeSH terms and keywords: "p53", "codon 72" "polymorphism" and "leukemia", or "lymphoma", or "myeloma", thirteen were identified as eligible articles in this meta-analysis for p53 Arg72Pro polymorphism (2,731 cases and 7, 356 controls), including nine studies on leukemia (1,266 cases and 4, 474 controls), three studies on lymphoma (1,359 cases and 2,652 controls), and one study on myeloma.
|
23029260 |
2012 |
|
rs878854066
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Through searching PubMed databases (or hand searching) up to April 2012 using the following MeSH terms and keywords: "p53", "codon 72" "polymorphism" and "leukemia", or "lymphoma", or "myeloma", thirteen were identified as eligible articles in this meta-analysis for p53 Arg72Pro polymorphism (2,731 cases and 7, 356 controls), including nine studies on leukemia (1,266 cases and 4, 474 controls), three studies on lymphoma (1,359 cases and 2,652 controls), and one study on myeloma.
|
23029260 |
2012 |